Copyright Reports & Markets. All rights reserved.

Global Cell Line Generation Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cell Line Generation by Type
    • 1.3.1 Overview: Global Cell Line Generation Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Cell Line Generation Consumption Value Market Share by Type in 2023
    • 1.3.3 Knockout Cell Lines
    • 1.3.4 Overexpression Cell Lines
    • 1.3.5 Inducible Expression Cell Lines
    • 1.3.6 Knockdown Cell Lines
    • 1.3.7 Knockin Cell Lines
    • 1.3.8 Others
  • 1.4 Global Cell Line Generation Market by Application
    • 1.4.1 Overview: Global Cell Line Generation Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pharmaceutical Industry
    • 1.4.3 Biological Industry
  • 1.5 Global Cell Line Generation Market Size & Forecast
  • 1.6 Global Cell Line Generation Market Size and Forecast by Region
    • 1.6.1 Global Cell Line Generation Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Cell Line Generation Market Size by Region, (2019-2030)
    • 1.6.3 North America Cell Line Generation Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Cell Line Generation Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Cell Line Generation Market Size and Prospect (2019-2030)
    • 1.6.6 South America Cell Line Generation Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Cell Line Generation Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Boehringer Ingelheim BioXcellence
    • 2.1.1 Boehringer Ingelheim BioXcellence Details
    • 2.1.2 Boehringer Ingelheim BioXcellence Major Business
    • 2.1.3 Boehringer Ingelheim BioXcellence Cell Line Generation Product and Solutions
    • 2.1.4 Boehringer Ingelheim BioXcellence Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Boehringer Ingelheim BioXcellence Recent Developments and Future Plans
  • 2.2 Lonza
    • 2.2.1 Lonza Details
    • 2.2.2 Lonza Major Business
    • 2.2.3 Lonza Cell Line Generation Product and Solutions
    • 2.2.4 Lonza Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Lonza Recent Developments and Future Plans
  • 2.3 WuXi Biologics
    • 2.3.1 WuXi Biologics Details
    • 2.3.2 WuXi Biologics Major Business
    • 2.3.3 WuXi Biologics Cell Line Generation Product and Solutions
    • 2.3.4 WuXi Biologics Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 WuXi Biologics Recent Developments and Future Plans
  • 2.4 Thermo Fisher Scientific
    • 2.4.1 Thermo Fisher Scientific Details
    • 2.4.2 Thermo Fisher Scientific Major Business
    • 2.4.3 Thermo Fisher Scientific Cell Line Generation Product and Solutions
    • 2.4.4 Thermo Fisher Scientific Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.5 Sartorius
    • 2.5.1 Sartorius Details
    • 2.5.2 Sartorius Major Business
    • 2.5.3 Sartorius Cell Line Generation Product and Solutions
    • 2.5.4 Sartorius Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sartorius Recent Developments and Future Plans
  • 2.6 Merck
    • 2.6.1 Merck Details
    • 2.6.2 Merck Major Business
    • 2.6.3 Merck Cell Line Generation Product and Solutions
    • 2.6.4 Merck Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Merck Recent Developments and Future Plans
  • 2.7 Catalent
    • 2.7.1 Catalent Details
    • 2.7.2 Catalent Major Business
    • 2.7.3 Catalent Cell Line Generation Product and Solutions
    • 2.7.4 Catalent Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Catalent Recent Developments and Future Plans
  • 2.8 Samsung Biologics
    • 2.8.1 Samsung Biologics Details
    • 2.8.2 Samsung Biologics Major Business
    • 2.8.3 Samsung Biologics Cell Line Generation Product and Solutions
    • 2.8.4 Samsung Biologics Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Samsung Biologics Recent Developments and Future Plans
  • 2.9 FUJIFILM Diosynth Biotechnologies
    • 2.9.1 FUJIFILM Diosynth Biotechnologies Details
    • 2.9.2 FUJIFILM Diosynth Biotechnologies Major Business
    • 2.9.3 FUJIFILM Diosynth Biotechnologies Cell Line Generation Product and Solutions
    • 2.9.4 FUJIFILM Diosynth Biotechnologies Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
  • 2.10 Porton Biologics
    • 2.10.1 Porton Biologics Details
    • 2.10.2 Porton Biologics Major Business
    • 2.10.3 Porton Biologics Cell Line Generation Product and Solutions
    • 2.10.4 Porton Biologics Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Porton Biologics Recent Developments and Future Plans
  • 2.11 Chempartner Pharmatech
    • 2.11.1 Chempartner Pharmatech Details
    • 2.11.2 Chempartner Pharmatech Major Business
    • 2.11.3 Chempartner Pharmatech Cell Line Generation Product and Solutions
    • 2.11.4 Chempartner Pharmatech Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Chempartner Pharmatech Recent Developments and Future Plans
  • 2.12 Rentschler Biopharma
    • 2.12.1 Rentschler Biopharma Details
    • 2.12.2 Rentschler Biopharma Major Business
    • 2.12.3 Rentschler Biopharma Cell Line Generation Product and Solutions
    • 2.12.4 Rentschler Biopharma Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Rentschler Biopharma Recent Developments and Future Plans
  • 2.13 ProBioGen
    • 2.13.1 ProBioGen Details
    • 2.13.2 ProBioGen Major Business
    • 2.13.3 ProBioGen Cell Line Generation Product and Solutions
    • 2.13.4 ProBioGen Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 ProBioGen Recent Developments and Future Plans
  • 2.14 AGC Biologics
    • 2.14.1 AGC Biologics Details
    • 2.14.2 AGC Biologics Major Business
    • 2.14.3 AGC Biologics Cell Line Generation Product and Solutions
    • 2.14.4 AGC Biologics Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 AGC Biologics Recent Developments and Future Plans
  • 2.15 OPM Biosciences
    • 2.15.1 OPM Biosciences Details
    • 2.15.2 OPM Biosciences Major Business
    • 2.15.3 OPM Biosciences Cell Line Generation Product and Solutions
    • 2.15.4 OPM Biosciences Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 OPM Biosciences Recent Developments and Future Plans
  • 2.16 Charles River Laboratories
    • 2.16.1 Charles River Laboratories Details
    • 2.16.2 Charles River Laboratories Major Business
    • 2.16.3 Charles River Laboratories Cell Line Generation Product and Solutions
    • 2.16.4 Charles River Laboratories Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.17 Mycenax Biotech
    • 2.17.1 Mycenax Biotech Details
    • 2.17.2 Mycenax Biotech Major Business
    • 2.17.3 Mycenax Biotech Cell Line Generation Product and Solutions
    • 2.17.4 Mycenax Biotech Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Mycenax Biotech Recent Developments and Future Plans
  • 2.18 JOINN Laboratories
    • 2.18.1 JOINN Laboratories Details
    • 2.18.2 JOINN Laboratories Major Business
    • 2.18.3 JOINN Laboratories Cell Line Generation Product and Solutions
    • 2.18.4 JOINN Laboratories Cell Line Generation Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 JOINN Laboratories Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cell Line Generation Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Cell Line Generation by Company Revenue
    • 3.2.2 Top 3 Cell Line Generation Players Market Share in 2023
    • 3.2.3 Top 6 Cell Line Generation Players Market Share in 2023
  • 3.3 Cell Line Generation Market: Overall Company Footprint Analysis
    • 3.3.1 Cell Line Generation Market: Region Footprint
    • 3.3.2 Cell Line Generation Market: Company Product Type Footprint
    • 3.3.3 Cell Line Generation Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cell Line Generation Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Cell Line Generation Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Cell Line Generation Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Cell Line Generation Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Cell Line Generation Consumption Value by Type (2019-2030)
  • 6.2 North America Cell Line Generation Market Size by Application (2019-2030)
  • 6.3 North America Cell Line Generation Market Size by Country
    • 6.3.1 North America Cell Line Generation Consumption Value by Country (2019-2030)
    • 6.3.2 United States Cell Line Generation Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Cell Line Generation Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Cell Line Generation Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Cell Line Generation Consumption Value by Type (2019-2030)
  • 7.2 Europe Cell Line Generation Consumption Value by Application (2019-2030)
  • 7.3 Europe Cell Line Generation Market Size by Country
    • 7.3.1 Europe Cell Line Generation Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Cell Line Generation Market Size and Forecast (2019-2030)
    • 7.3.3 France Cell Line Generation Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Cell Line Generation Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Cell Line Generation Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Cell Line Generation Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cell Line Generation Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Cell Line Generation Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Cell Line Generation Market Size by Region
    • 8.3.1 Asia-Pacific Cell Line Generation Consumption Value by Region (2019-2030)
    • 8.3.2 China Cell Line Generation Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Cell Line Generation Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Cell Line Generation Market Size and Forecast (2019-2030)
    • 8.3.5 India Cell Line Generation Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Cell Line Generation Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Cell Line Generation Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Cell Line Generation Consumption Value by Type (2019-2030)
  • 9.2 South America Cell Line Generation Consumption Value by Application (2019-2030)
  • 9.3 South America Cell Line Generation Market Size by Country
    • 9.3.1 South America Cell Line Generation Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Cell Line Generation Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Cell Line Generation Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cell Line Generation Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Cell Line Generation Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Cell Line Generation Market Size by Country
    • 10.3.1 Middle East & Africa Cell Line Generation Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Cell Line Generation Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Cell Line Generation Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Cell Line Generation Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Cell Line Generation Market Drivers
  • 11.2 Cell Line Generation Market Restraints
  • 11.3 Cell Line Generation Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cell Line Generation Industry Chain
  • 12.2 Cell Line Generation Upstream Analysis
  • 12.3 Cell Line Generation Midstream Analysis
  • 12.4 Cell Line Generation Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Cell line generation (CLG) in the scope of bioproduction can be defined as a method to isolate a single cell expressing a recombinant protein of interest.
    According to our (Global Info Research) latest study, the global Cell Line Generation market size was valued at US$ 1855 million in 2023 and is forecast to a readjusted size of USD 3525 million by 2030 with a CAGR of 9.7% during review period.
    Global key players of cell line generation include Boehringer Ingelheim BioXcellence, Lonza, WuXi Biologics, Thermo Fisher Scientific, etc. Global top five manufacturers hold a share over 39%. In terms of product, knockout cell lines are the largest segment, with a share over 49%. And in terms of application, the largest application is pharmaceutical industry, with a share over 70%.
    This report is a detailed and comprehensive analysis for global Cell Line Generation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Cell Line Generation market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Cell Line Generation market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Cell Line Generation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Cell Line Generation market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cell Line Generation
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cell Line Generation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim BioXcellence, Lonza, WuXi Biologics, Thermo Fisher Scientific, Sartorius, Merck, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Porton Biologics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Cell Line Generation market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Cell Line Generation market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Knockout Cell Lines
    Overexpression Cell Lines
    Inducible Expression Cell Lines
    Knockdown Cell Lines
    Knockin Cell Lines
    Others
    Market segment by Application
    Pharmaceutical Industry
    Biological Industry
    Market segment by players, this report covers
    Boehringer Ingelheim BioXcellence
    Lonza
    WuXi Biologics
    Thermo Fisher Scientific
    Sartorius
    Merck
    Catalent
    Samsung Biologics
    FUJIFILM Diosynth Biotechnologies
    Porton Biologics
    Chempartner Pharmatech
    Rentschler Biopharma
    ProBioGen
    AGC Biologics
    OPM Biosciences
    Charles River Laboratories
    Mycenax Biotech
    JOINN Laboratories
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Cell Line Generation product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Cell Line Generation, with revenue, gross margin, and global market share of Cell Line Generation from 2019 to 2024.
    Chapter 3, the Cell Line Generation competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cell Line Generation market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Line Generation.
    Chapter 13, to describe Cell Line Generation research findings and conclusion.

    Buy now